Amgen Inc.
CH ˙ SWX ˙ NL0000888691
SecurityCH:AMGN / Amgen Inc.
InstitutionDodge & Cox
Latest Disclosed Ownership13,367 shares
Latest Disclosed Value $ 4,703,179
Dodge & Cox ownership in AMGN / Amgen Inc.

On May 14, 2026 - Dodge & Cox filed a 13F-HR form disclosing ownership of 13,367 shares of Amgen Inc. (CH:AMGN) valued at $4,703,179 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 13,367 shares of Amgen Inc.. This represents a change in shares of 0.00% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F Amgen COM 031162100 13,367 0 0.00 4,703 7.50 0.0026
2026-02-13 2025-12-31 13F Amgen COM 031162100 13,367 0 0.00 4,375 15.99 0.0024
2025-11-13 2025-09-30 13F Amgen COM 031162100 13,367 -315 -2.30 3,772 -1.26 0.0020
2025-08-13 2025-06-30 13F Amgen COM 031162100 13,682 150 1.11 3,820 -9.37 0.0021
2025-05-14 2025-03-31 13F Amgen COM 031162100 13,532 -750 -5.25 4,216 13.25 0.0024
2025-02-13 2024-12-31 13F Amgen COM 031162100 14,282 0 0.00 3,722 -19.10 0.0022
2024-11-13 2024-09-30 13F Amgen COM 031162100 14,282 -100 -0.70 4,602 2.40 0.0026
2024-08-13 2024-06-30 13F Amgen COM 031162100 14,382 0 0.00 4,494 9.88 0.0027
2024-05-14 2024-03-31 13F Amgen COM 031162100 14,382 0 0.00 4,089 -1.28 0.0024
2024-02-22 2023-12-31 13F/A-1 Amgen COM 031162100 14,382 0 0.00 4,142 7.17 0.0026
2024-02-15 2023-12-31 13F Amgen COM 031162100 14,382 0 4,142 0.0026
2023-11-14 2023-09-30 13F Amgen COM 031162100 14,382 -100 -0.69 3,865 20.22 0.0026
2023-08-14 2023-06-30 13F Amgen COM 031162100 14,482 -525 -3.50 3,215 -11.36 0.0021
2023-05-12 2023-03-31 13F Amgen COM 031162100 15,007 -1,200 -7.40 3,628 -14.78 0.0025
2023-02-14 2022-12-31 13F Amgen COM 031162100 16,207 0 0.00 4,257 16.51 0.0029
2022-11-10 2022-09-30 13F Amgen COM 031162100 16,207 -300 -1.82 3,653 -9.04 0.0028
2022-08-12 2022-06-30 13F Amgen COM 031162100 16,507 -100 -0.60 4,016 0.00 0.0028
2022-05-13 2022-03-31 13F Amgen COM 031162100 16,607 0 0.00 4,016 7.49 0.0024
2022-02-14 2021-12-31 13F Amgen COM 031162100 16,607 -300 -1.77 3,736 3.92 0.0023
2021-11-15 2021-09-30 13F Amgen COM 031162100 16,907 0 0.00 3,595 -12.76 0.0023
2021-08-13 2021-06-30 13F Amgen COM 031162100 16,907 -880 -4.95 4,121 -6.89 0.0027
2021-05-14 2021-03-31 13F Amgen COM 031162100 17,787 -70 -0.39 4,426 7.79 0.0032
2021-02-11 2020-12-31 13F Amgen COM 031162100 17,857 -1,100 -5.80 4,106 -14.78 0.0032
2020-11-13 2020-09-30 13F Amgen COM 031162100 18,957 -1,185 -5.88 4,818 1.41 0.0044
2020-08-13 2020-06-30 13F Amgen COM 031162100 20,142 -655 -3.15 4,751 12.69 0.0044
2020-05-14 2020-03-31 13F Amgen COM 031162100 20,797 -575 -2.69 4,216 -18.17 0.0046
2020-02-13 2019-12-31 13F Amgen COM 031162100 21,372 -25 -0.12 5,152 24.41 0.0039
2019-11-13 2019-09-30 13F Amgen COM 031162100 21,397 -225 -1.04 4,141 3.91 0.0034
2019-08-13 2019-06-30 13F Amgen COM 031162100 21,622 -200 -0.92 3,985 -3.88 0.0032
2019-05-14 2019-03-31 13F Amgen COM 031162100 21,822 -600 -2.68 4,146 -5.02 0.0034
2019-02-14 2018-12-31 13F Amgen COM 031162100 22,422 -600 -2.61 4,365 -8.53 0.0040
2018-11-21 2018-09-30 13F/A-1 Amgen COM 031162100 23,022 -1,300 -5.34 4,772 6.28 0.0037
2018-11-14 2018-09-30 13F Amgen COM 031162100 23,022 -1,300 4,772
2018-08-14 2018-06-30 13F Amgen COM 031162100 24,322 -450 -1.82 4,490 6.32 0.0036
2018-05-14 2018-03-31 13F Amgen COM 031162100 24,772 -1,925 -7.21 4,223 -9.05 0.0034
2018-02-14 2017-12-31 13F Amgen COM 031162100 26,697 -1,140 -4.10 4,643 -10.54 0.0036
2017-11-13 2017-09-30 13F Amgen COM 031162100 27,837 -3,300 -10.60 5,190 -3.23 0.0042
2017-08-11 2017-06-30 13F Amgen COM 031162100 31,137 -1,000 -3.11 5,363 1.71 0.0045
2017-05-12 2017-03-31 13F Amgen COM 031162100 32,137 -7,070 -18.03 5,273 -8.01 0.0045
2017-03-20 2016-12-31 13F/A-1 Amgen COM 031162100 39,207 -950 -2.37 5,732 -14.43 0.0051
2017-02-14 2016-12-31 13F Amgen COM 031162100 39,207 5,732
2016-11-14 2016-09-30 13F Amgen COM 031162100 40,157 -1,100 -2.67 6,699 6.72 0.0063
2016-08-12 2016-06-30 13F Amgen COM 031162100 41,257 -2,300 -5.28 6,277 -3.89 0.0062
2016-05-13 2016-03-31 13F Amgen COM 031162100 43,557 -3,087 -6.62 6,531 -13.75 0.0064
2016-02-12 2015-12-31 13F Amgen COM 031162100 46,644 -1,700 -3.52 7,572 13.23 0.0074
2015-11-12 2015-09-30 13F Amgen COM 031162100 48,344 -2,460 -4.84 6,687 -14.26 0.0067
2015-08-13 2015-06-30 13F Amgen COM 031162100 50,804 -3,900 -7.13 7,799 -10.81 0.0070
2015-05-14 2015-03-31 13F Amgen COM 031162100 54,704 -11,723 -17.65 8,744 -17.36 0.0081
2015-02-13 2014-12-31 13F Amgen COM 031162100 66,427 -6,480 -8.89 10,581 3.32 0.0098
2014-11-13 2014-09-30 13F AMGEN COM 031162100 72,907 -12,950 -15.08 10,241 0.77 0.0098
2014-08-13 2014-06-30 13F AMGEN COM 031162100 85,857 -19,900 -18.82 10,163 -22.09 0.0097
2014-05-14 2014-03-31 13F AMGEN COM 031162100 105,757 -30,863 -22.59 13,044 -16.37 0.0133
2014-02-14 2013-12-31 13F AMGEN COM 031162100 136,620 -23,432 -14.64 15,597 -12.94 0.0163
2013-11-13 2013-09-30 13F AMGEN COM 031162100 160,052 -101,170 -38.73 17,916 -30.48 0.0204
2013-08-13 2013-06-30 13F AMGEN COM 031162100 261,222 261,222 25,772 0.0306
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.